Speakers

Expand/Collapse

Brian Booth
Principal Scientist
Shape Therapeutics

Day One

Tuesday April 5, 2022

11:45 am | Enhanced gRNA Expression & Recruitment of Endogenous ADAR to Drive Robust RNA Editing in vivo

Daniel Rosan
Chief Business & Financial Officer
Ascidian Therapeutics

Day Two

Wednesday April 6, 2022

3:15 pm | Re-Engineering the Transcriptome via RNA Exon Editing: A Novel Therapeutic Approach

Dave Mauger
Director of Data Science
Arrakis Therapeutics

Day Two

Wednesday April 6, 2022

12:15 pm | Discovering Targetable mRNA Structures in the Transcriptome

David Guay
Vice President of Innovation
Feldan Therapeutics

Day Two

Wednesday April 6, 2022

2:15 pm | Shuttle Peptides Enable Delivery of Splice Switching ASOs to Airway Epithelial Cells

Pre-Conference Day

Sunday 11th June 2023

12:00 pm | Assessing Novel Delivery Technologies to Achieve Specific Targeting

Feng Damon Wang
Post Doc Associate, Jon Watts Lab (RNA Therapeutics Institute
UMass Chan Medical School

Day Two

Wednesday April 6, 2022

3:45 pm | G-Rich Motifs within Phosphorothioate-Based ASOs Drive Activation of FXN Expression through Indirect Effects

Gerard Platenburg
Chief Scientific Officer & Co-Founder
ProQR

Day One

Tuesday April 5, 2022

4:00 pm | Harnessing RNA Chemical Modifications to Improve the Potency & Yield of ADAR

Gurumurthy Channabasavaiah
Professor
Nebraska Medical Center

Pre-Conference Day

Sunday 11th June 2023

12:00 pm | Assessing Novel Delivery Technologies to Achieve Specific Targeting

Hagen Cramer
Chief Production Officer
QurAlis

Pre-Conference Day

Sunday 11th June 2023

3:00 pm | Unlocking Efficient Oligonucleotide Manufacturing in Line with Regulatory Expectations

Ian Harding
Scientist II
Wave Life Sciences

Day One

Tuesday April 5, 2022

3:30 pm | Pioneering New Applications of RNA Editing & Reaching Larger Patient Populations

Jonathan Gootenberg
McGovern Fellow
MIT

Day One

Tuesday April 5, 2022

10:15 am | New Molecular Technologies for RNA Editing & Control

Kunwoo Lee
Chief Executive Officer & Co-founder
GenEdit

Day One

Tuesday April 5, 2022

2:30 pm | Non-Lipid Delivery of Genome Editing with Hydrophilic Nanoparticles

Mateusz Maciejewski
Vice President, Head of Data Science
Korro Bio

Day Two

Wednesday April 6, 2022

11:15 am | Applying Data Science & Machine Learning Approaches to Improve Efficacy of ADAR

Miriam Bujny
Chief Development Officer
Sapreme Technologies

Day One

Tuesday April 5, 2022

2:00 pm | Efficient On-Target Delivery of Oligonucleotides (& Beyond): in vitro & in vivo Performance of Sapreme’s Endosomal Escape Enhancers for Various Tissues & Targets

Mohamed ElSayed
Executive Vice President & Chief Technology Officer
RVAC Medicines

Day One

Tuesday April 5, 2022

9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics

Nagy Habib
Head of Research
MiNA Therapeutics

Day One

Tuesday April 5, 2022

9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics

Pre-Conference Day

Sunday 11th June 2023

9:00 am | Leveraging ADAR & APOBEC to Reactivate Downregulated Genes in Rare Disease

Naveen Krishnan
Senior Director of Venture Investment
Bayer

Day Two

Wednesday April 6, 2022

9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies

Omar Abudayyeh
McGovern Fellow
MIT

Day One

Tuesday April 5, 2022

10:15 am | New Molecular Technologies for RNA Editing & Control

Paul Bolno
President & Chief Executive Officer
Wave Life Sciences

Day One

Tuesday April 5, 2022

9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics

Day Two

Wednesday April 6, 2022

9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies

Prashant Monian
Senior Scientist
Wave Life Sciences

Day One

Tuesday April 5, 2022

9:00 am | The First Clinical Candidate for RNA Editing

Raj Pandey
Vice President of Chemistry
Cargene

Pre-Conference Day

Sunday 11th June 2023

3:00 pm | Unlocking Efficient Oligonucleotide Manufacturing in Line with Regulatory Expectations

Ron Hause
Vice President & Head of Analytics & Informatics
Shape Therapeutics

Day Two

Wednesday April 6, 2022

11:45 am | Generative Machine Learning Enables DGuide RNA Design for Precise RNA Editing

Ron Weiss
Professor
MIT

Day One

Tuesday April 5, 2022

4:30 pm | Developing a New Control System for Synthetic Genes to Control the Payload in Efforts to Improve Potency & Durability

Sandy Hinckley
Senior Director, Head of Discovery Biology
QurAlis

Day Two

Wednesday April 6, 2022

1:45 pm | Case Study: Recent Advances in Splice Switching ASOs for CNS Diseases

Steven Seedhouse
Managing Director, Biotechnology Equity Research
Raymond James

Day Two

Wednesday April 6, 2022

9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies

Thomas de Vlaam
Principal
VC Pillar

Day Two

Wednesday April 6, 2022

9:00 am | Mapping the RNA Editing R&D Landscape: A 2023 Forecast

Venkata Krishnamurthy
Senior Vice President, Head of Platform
Korro Bio

Day One

Tuesday April 5, 2022

8:50 am | Chair’s Opening Remarks

9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics

5:00 pm | Chair’s Closing Remarks